Advertisement

Reactions Weekly

, Volume 1673, Issue 1, pp 135–135 | Cite as

Crizotinib/vemurafenib

Development of resistance in metastatic colorectal cancer followed by cancer progression: case report
Case report
  • 17 Downloads

Reference

  1. Oddo D, et al. Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer. British Journal of Cancer 117: 347-352, No. 3, 25 Jul 2017. Available from: URL: http://doi.org/10.1038/bjc.2017.196 -Italy

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations